ライフサイエンスコーパス: mean transit time

1 5-1.4% for distribution volume, and 0.0% for mean transit time.

2 3% for distribution volume, and 0.2-1.8% for mean transit time.

3 ose groups (45 and 30 mg), except for DCE CT mean transit time.

4 ividuals without CCSVI, without any delay in mean transit time.

5 distal pressure multiplied by the hyperemic mean transit time.

6 od flow, relative cerebral blood volume, and mean transit time.

7 al blood volume (6-33% decrease), and tissue mean transit time (10-54% increase) were observed in the

8 s, p = 0.03, respectively) and a decrease in mean transit time (31 +/- 8 vs 60 +/- 2 s, p = 0.04, res

9 Mean transit time and blood volume fraction were compara

10 Brain perfusion (mean transit time and blood volume fraction) was compara

11 sing quantitative voxel based thresholds for mean transit time and cerebral blood volume (CBV).

12 striatal necrosis in an 8-month-old infant, mean transit time and cerebral blood volume were low rel

13 aminal lesions, striatal flow was normal but mean transit time and cerebral blood volume were low, co

14 lood brain barrier (BBB), reducing capillary mean transit time and GCRs.

15 usion coefficient, tissue oxygen saturation, mean transit time, and blood volume fraction in the cort

16 s per group); local brain oxygen saturation, mean transit time, and blood volume fraction were subseq

17 o calculate tissue blood flow, blood volume, mean transit time, and permeability-surface area product

18 asurement of tumor blood flow, blood volume, mean transit time, and permeability-surface area product

19 Visual analysis and mean transit time calculation were performed on the rest

20 ime, elevated cerebral blood volume and high mean transit time/cerebral blood flow and cerebral blood

21 gged correlation and compared the results to mean transit time derived using bolus tracking.

22 ured) had low cerebral blood flow, prolonged mean transit time, elevated cerebral blood volume and hi

23 The inverse of the hyperemic mean transit time has been shown to correlate with absol

24 The MS group showed prolonged mean transit time in the periventricular NAWM, as compar

25 raction in tumors and normal tissue, and for mean transit time in tumors; however, permeability value

26 monstrated by a 3-fold increase in ribosomal mean transit times in cell-free extracts from hibernator

27 (Pcs), right atrial pressure (Pra), and the mean transit time (inverse of blood flow [Tmn]), were me

28 .90) than did those on blood flow and tracer mean transit time maps (r approximately 0.6), likely as

29 as the difference between lesion volumes on mean transit time maps and DW images, divided by DW lesi

30 algorithm identifies hypoperfused tissue in mean transit time maps by simultaneously minimizing the

31 BV), absolute cerebral blood flow (CBF), and mean transit time (MTT) (referenced to an arterial input

32 volume (BV), and lower (>0.30 and >0.39) for mean transit time (MTT) and permeability surface area pr

33 Parameter maps for mean transit time (MTT) and plasma flow (PF) were evalua

34 The parenchymal mean transit time (MTT) is theoretically superior to oth

35 ved brain perfusion: hypoperfusion volume on mean transit time (MTT) map decrease >30% from baseline

36 fraction (PV), distribution volume (DV), and mean transit time (MTT) of gadopentetate dimeglumine.

37 the glomerular filtration rate (GFR) and the mean transit time (MTT) of the tracer for the vascular c

38 erive blood flow (BF), blood volume (BV) and mean transit time (MTT) perfusion maps.

39 f mean CBF, cerebral blood volume (CBV), and mean transit time (MTT) were determined between hemisphe

40 Blood flow (BF), blood volume (BV), mean transit time (MTT), and capillary permeability-surf

41 Blood flow (BF), blood volume (BV), mean transit time (MTT), and permeability-surface area p

42 Blood flow (BF), blood volume (BV), mean transit time (MTT), and permeability-surface area p

43 Distribution volume (DV), mean transit time (MTT), and portal fraction (PF) of blo

44 culate tissue blood flow (BF), blood volume, mean transit time (MTT), and vascular permeability-surfa

45 Blood flow, blood volume, mean transit time (MTT), permeability-surface area produ

46 ity, blood volume (BV), blood flow (BF), and mean transit time (MTT), were calculated at the primary

47 parameters, pulmonary blood flow (PBF), and mean transit time (MTT).

48 flow (CBF), cerebral blood volume (CBV), and mean transit time (MTT).

49 ncluding Blood Flow (BF), Blood Volume (BV), Mean Transit Time (MTT)] and permeability parameters [in

50 ed software, it is possible to calculate the mean transit time of room-temperature saline injected do

51 farct volume (SE = 80%; SP = 97%), Increased mean transit time on PCT was predictive of the tissue at

52 , total blood flow, distribution volume, and mean transit time) parameters were calculated by placing

53 o determine tissue blood flow, blood volume, mean transit time, permeability, and hepatic arterial fr

54 Blood flow, mean transit time, permeability, and hepatic arterial fr

55 sure divided by the inverse of the hyperemic mean transit time provides an index of microcirculatory

56 ebral blood flow, cerebral blood volume, and mean transit time, respectively.

57 Hg; balloon: 79 [75-93] mm Hg; P = .01) and mean transit time (sham: 0.39 [0.23-0.62] s; balloon: 0.

58 lower portal flow, distribution volume, and mean transit time than did the background liver (all P <

59 oronary pressure, whereas the inverse of the mean transit time to room temperature saline was used to

60 , and positive correlation was found between mean transit time values and disability scales in patien

61 volume (CBV), cerebral blood flow (CBF), and mean transit time were assessed with dynamic susceptibil